Vitamin D and cancer.

The correlation between decreased morbidity and mortality of cancer and exposure to sunlight is known. The many biological functions of vitamin D that contribute to cancer prevention have only recently begun to be appreciated. Once activated 1,25-dihydroxyvitamin D [1,25(OH)2D3] functions as a potent inhibitor of normal and cancer cellular proliferation. Vitamin D deficiency in mice led to a 60% increase in colon tumor growth, compared to vitamin D-sufficient mice. The ligand binding domain of the Vitamin D receptor was shown to accommodate a class of 1,25(OH)2D3-analogs that possess an additional side-arm. These novel Gemini analogs were evaluated in vitro and in vivo. Select Gemini analogs were 100 times or more effective in inhibiting colon tumor growth in mice, compared to their parent compound. Correcting vitamin D deficiency may decrease the risk of developing colon cancer, while the novel Gemini 1,25(OH)2D3-analogs have the potential for therapeutic application in human colon cancer.

[1]  S. Mohr,et al.  What is the dose-response relationship between vitamin D and cancer risk? , 2007, Nutrition reviews.

[2]  J. Moan,et al.  Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: A possible role of sun-induced Vitamin D , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  J. Moan,et al.  Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? , 2007, Lung cancer.

[4]  J. Michael Gaziano,et al.  A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer , 2007, PLoS medicine.

[5]  M. Holick,et al.  Comparisons of Estimated Economic Burdens due to Insufficient Solar Ultraviolet Irradiance and Vitamin D and Excess Solar UV Irradiance for the United States , 2005, Photochemistry and photobiology.

[6]  M. Holick,et al.  Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  M. Holick,et al.  Vitamin D intakes by children and adults in the United States differ among ethnic groups. , 2005, The Journal of nutrition.

[8]  Marta García,et al.  1α,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells , 2005, Oncogene.

[9]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[10]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[11]  P. Tuohimaa,et al.  The role of Vitamin D3 metabolism in prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  B. Hollis,et al.  Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  C. Heldin,et al.  Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.

[14]  U. Fischer,et al.  Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D31α-hydroxylase in brain and skin cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  H. Adlercreutz,et al.  Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. , 2004, The Journal of nutrition.

[16]  R. Vieth.  Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  M. Holick,et al.  Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.

[18]  N. Raghavachari,et al.  Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray , 2003, Breast Cancer Research and Treatment.

[19]  C. Garland,et al.  Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. , 2003, Annals of epidemiology.

[20]  C. Carlberg,et al.  Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. , 2003, Molecular pharmacology.

[21]  M. Holick.  VITAMIN D: A MILLENNIUM PERSPECTIVE , 2003 .

[22]  P. Hutchinson,et al.  Vitamin D and systemic cancer: is this relevant to malignant melanoma? , 2002, The British journal of dermatology.

[23]  D. Trump,et al.  Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells. , 2002, Endocrinology.

[24]  M. Holick,et al.  25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  W. Grant.  An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation , 2002, Cancer.

[26]  G. Miller,et al.  Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. , 2001, Cancer research.

[27]  T. Chen,et al.  Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.

[28]  M. Holick,et al.  25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue , 2001, The Lancet.

[29]  D. Feldman,et al.  The role of vitamin D in prostate cancer , 2001, Steroids.

[30]  T. Baudino,et al.  Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription , 2001, Steroids.

[31]  D. Moras,et al.  Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. , 2001, European journal of biochemistry.

[32]  S. Rockman,et al.  Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. , 2001, The Journal of biological chemistry.

[33]  A. Howie,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Extrarenal Expression of 25-Hydroxyvitamin , 2022 .

[34]  M. Haussler,et al.  Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3. , 2000, Biochemistry.

[35]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[36]  A. Cercek,et al.  Involvement of the Helix-Loop-Helix Protein Id-1 in the Glucocorticoid Regulation of Tight Junctions in Mammary Epithelial Cells* , 2000, The Journal of Biological Chemistry.

[37]  N. Bundred,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .

[38]  H. Koeffler,et al.  Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. , 2000, Journal of medicinal chemistry.

[39]  C. Mathieu,et al.  Identification and immune regulation of 25‐hydroxyvitamin D‐1‐α‐hydroxylase in murine macrophages , 2000, Clinical and experimental immunology.

[40]  S. Cramer,et al.  25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  D. Moras,et al.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.

[42]  J. Barsony,et al.  Hormone-dependent Translocation of Vitamin D Receptors Is Linked to Transactivation* , 1999, The Journal of Biological Chemistry.

[43]  J. Barsony,et al.  Vitamin D Receptor Translocation , 1999 .

[44]  C. Garland,et al.  Epidemiology of Cancer Risk and Vitamin D , 1999 .

[45]  T. Chen,et al.  Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  M. Hayman,et al.  The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42 , 1998, Oncogene.

[47]  C. Garland,et al.  Sunlight, vitamin D, and ovarian cancer mortality rates in US women. , 1994, International journal of epidemiology.

[48]  D. Feldman,et al.  Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. , 1993, Endocrinology.

[49]  J. F. Young,et al.  Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. , 1990, Preventive medicine.

[50]  C. Garland,et al.  Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. , 1989, Canadian journal of public health = Revue canadienne de sante publique.

[51]  D. Bikle,et al.  Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. , 1986, Biochemistry.

[52]  J. Eisman,et al.  Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. , 1983, Cancer research.

[53]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.

[54]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.

[55]  S. Peller.  CARCINOGENESIS AS A MEANS OF REDUCING CANCER MORTALITY , 1936 .

[56]  K. Huldschinsky.  Heilung von Rachitis durch künstliche Höhensonne , 1919 .

[57]  C. Winslow,et al.  The Mortality from Cancer Throughout the World , 1916, The Indian Medical Gazette.

[58]  D. Cole,et al.  Evidence that vitamin D 3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D 2 1 – 3 , 2022 .